Vasotensin® provides peptides from bonito fish to support healthy blood pressure levels already in the normal range. Bonito peptides have been shown to reduce the formation of angiotensin II—a potent vasoconstrictor—through their interaction with angiotensin-converting enzyme. This formula is designed to be fast acting and to provide a clinically effective dose in just 2 tablets twice daily.*
Storage: Keep tightly closed in a cool, dry place.
Formulated to Exclude: Wheat, gluten, soy, dairy products, egg, nuts, tree nuts, crustacean shellfish, colors, artificial flavors, artificial sweeteners, and preservatives.
|Protein||less than 1 gram|
|Fish Protein Powder (from Sarda orientalis†)||750 mg||*|
Ingredients: Microcrystalline cellulose, fish protein powder [fish (bonito)], cellulose, stearic acid (vegetable), silica, croscarmel-lose sodium, and magnesium stearate (vegetable).
Contains: fish (bonito).
Bonito peptides have not demonstrated a negative influence on healthy blood pressure levels, and have an excellent predicted safety profile that suggests appropriate long-term use with clinical supervision. And no rebound (reverse) effect was observed in clinical studies after bonito peptide supplementation was discontinued. The active bonito peptides in Vasotensin are derived from a patented process and tested to verify the presence of LKPNM, identified as the most active peptide.*
Each tablet provides a clinically effective dose of active peptides (proteins) from a fish known as bonito in Japan. These peptides help prevent the formation of angiotensin II (which constricts blood vessels) through their interaction with angiotensin converting enzyme. This activity supports healthy blood vessel function and blood flow ( circulation).*
In 2 randomized, placebo-controlled clinical studies, bonito peptides (the same as in Vasotensin) demonstrated significantly greater support for healthy blood pressure levels than placebo. Noticeable support in both studies was seen after just 2 weeks. Individual results may vary. For best results, follow your health care professional's recommendations.*
Health care professionals recommend this product to promote cardiovascular health, including support for vascular ( blood vessel ) health and maintenance of blood pressure levels already within the normal range.*
No serious adverse effects have been observed for bonito peptides in clinical studies up to 16 weeks. Bonito peptides have been the subject of multiple animal and human studies, and were granted FOSHU (Food of Specified Health Use) status in Japan in 1997. Plus, Metagenics' manufacturing facility has 3 certifications for good manufacturing practices to ensure the highest quality.
Caution: If pregnant or nursing, or taking medication, consult your healthcare practitioner before use. Keep out of the reach of children.
†U.S Patent Nos. 5,314,807; 5,369,015